These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 14512309)
21. PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology. Gonias SL; Banki MA; Gilder AS; Azmoon P; Campana WM; Mantuano E J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29930084 [TBL] [Abstract][Full Text] [Related]
22. Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin. Padró T; Quax PH; van den Hoogen CM; Roholl P; Verheijen JH; Emeis JJ Arterioscler Thromb; 1994 Sep; 14(9):1459-65. PubMed ID: 8068608 [TBL] [Abstract][Full Text] [Related]
23. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow. Graham DA; Huang TC; Keyt BA; Alevriadou BR Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163 [TBL] [Abstract][Full Text] [Related]
24. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor. Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275 [TBL] [Abstract][Full Text] [Related]
25. Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1. Kim JW; Lee SH; Ko HM; Kwon KJ; Cho KS; Choi CS; Park JH; Kim HY; Lee J; Han SH; Ignarro LJ; Cheong JH; Kim WK; Shin CY Neurochem Int; 2011 Feb; 58(3):423-33. PubMed ID: 21193004 [TBL] [Abstract][Full Text] [Related]
26. tPA Point Mutation at Autolysis Loop Enhances Resistance to PAI-1 Inhibition and Catalytic Activity. Peng S; Xue G; Chen S; Chen Z; Yuan C; Li J; Huang M Thromb Haemost; 2019 Jan; 119(1):77-86. PubMed ID: 30597502 [TBL] [Abstract][Full Text] [Related]
27. Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice. Molinas CR; Elkelani O; Campo R; Luttun A; Carmeliet P; Koninckx PR Fertil Steril; 2003 Jul; 80(1):184-92. PubMed ID: 12849822 [TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator. Björquist P; Brohlin M; Ehnebom J; Ericsson M; Kristiansen C; Pohl G; Deinum J Biochim Biophys Acta; 1994 Dec; 1209(2):191-202. PubMed ID: 7811690 [TBL] [Abstract][Full Text] [Related]
30. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis. Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948 [TBL] [Abstract][Full Text] [Related]
31. [Role of tissue plasminogen activator in the rewarding effect of morphine]. Nagai T; Nabeshima T; Takuma K; Yamada K Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Feb; 41(1):23-30. PubMed ID: 16619846 [TBL] [Abstract][Full Text] [Related]
32. Prolactin regulation of tissue type plasminogen activator and plasminogen activator inhibitor type-I gene expression in eCG-primed rat granulosa cells in culture. Liu YX; Peng XR; Liu HZ; Chen YJ; Ny T Biol Reprod; 1998 Aug; 59(2):409-16. PubMed ID: 9687315 [TBL] [Abstract][Full Text] [Related]
33. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator. Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178 [TBL] [Abstract][Full Text] [Related]
37. Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation. Peng XR; Hsueh AJ; Ny T Eur J Biochem; 1993 May; 214(1):147-56. PubMed ID: 8508786 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a small molecule PAI-1 inhibitor, ZK4044. Liang A; Wu F; Tran K; Jones SW; Deng G; Ye B; Zhao Z; Snider RM; Dole WP; Morser J; Wu Q Thromb Res; 2005; 115(4):341-50. PubMed ID: 15668194 [TBL] [Abstract][Full Text] [Related]
39. DRL performance in mice with deletion of tPA, uPA or PAI-1 genes. Horwood JM; Ripley TL; Stephens DN Behav Pharmacol; 2001 Nov; 12(6-7):487-96. PubMed ID: 11742143 [TBL] [Abstract][Full Text] [Related]
40. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation. Xiaoli M; Wenying H; Mingpeng S Int J Cardiol; 1998 Oct; 66 Suppl 1():S57-64; discussion S65. PubMed ID: 9951803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]